The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyPerspectives of nanotechnology in minimally invasive therapy of breast cancerStructure and dynamics of drug carriers and their interaction with cellular receptors: focus on serum transferrinToward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesTransferrin-mediated cellular iron deliveryNanoparticle ligand presentation for targeting solid tumorsNanomedicine therapeutic approaches to overcome cancer drug resistanceNanotechnology in cancer therapyImproved eIF4E Binding Peptides by Phage Display Guided Design: Plasticity of Interacting Surfaces Yield Collective EffectsNANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Polymer nanostructures synthesized by controlled living polymerization for tumor-targeted drug deliveryMRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the BrainA Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal AdenocarcinomaNanotechnology in the war against cancer: new arms against an old enemy - a clinical view.Automated selection of regions of interest for intensity-based FRET analysis of transferrin endocytic trafficking in normal vs. cancer cellsA nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.Non-invasive in vivo imaging of near infrared-labeled transferrin in breast cancer cells and tumors using fluorescence lifetime FRET.Iron and cancer: more ore to be mined.Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesTransferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunitiesTargeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.Endocytosis of a functionally enhanced GFP-tagged transferrin receptor in CHO cells.Plasmonic nanodiamonds: targeted core-shell type nanoparticles for cancer cell thermoablationEvaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles.Functionalized nano-graphene oxide particles for targeted fluorescence imaging and photothermy of glioma U251 cellsEvaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics.Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPasePEG-b-AGE Polymer Coated Magnetic Nanoparticle Probes with Facile Functionalization and Anti-fouling Properties for Reducing Non-specific Uptake and Improving Biomarker Targeting.Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.Receptor Crosslinking: A General Method to Trigger Internalization and Lysosomal Targeting of Therapeutic Receptor:Ligand Complexes.Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.TfR1 interacts with the IKK complex and is involved in IKK-NF-κB signallingTargeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.
P2860
Q26745710-AA45283B-F705-487F-91FF-E8606003AA33Q26828806-4407034D-EF45-4983-8550-661D2C9FA03FQ26853427-91CF4F82-7A35-4B97-A118-4B61C8E836D9Q26995399-4AFF8135-07BE-4324-88CC-05B89F9A137FQ27004133-52F94ABF-2ABA-43E0-91E3-78DEEC718142Q27009522-0902CDD8-B6D2-4AE0-BF9D-079644E6BBD5Q27011692-D9A36746-A9C5-450B-9C8B-7752E38DE0ABQ27023013-2EB2B350-3E96-4185-8A73-80FBD1642A32Q27674708-6F03289D-7000-4753-B991-EF916825A6E6Q28078448-7CA4BA97-9827-4BE0-81E7-5CA78A1D1312Q28085664-775972E6-AA48-4A3F-A6ED-631752BD1F45Q29248327-6A128B01-54DC-4079-A98E-AEE0C72525D6Q30275702-B4D75072-FBF0-462D-AC56-A578E5CC4F41Q30376531-F0E06B4C-9027-4B67-A5E4-28F17879A3CDQ30407485-4AC3EAB4-A4E7-44DD-A884-D186ED501C56Q30412393-E87B00D0-B699-437E-BAF7-F62A7D24E539Q30416226-A5B1CA12-4B2D-46D2-9207-BF5807574810Q33677592-B32E4108-EA90-484E-936C-BAD9216C62FCQ33761744-3683C7CD-1230-4DF3-ACF9-4B14DDD040B8Q33824400-E8C1381B-6202-4742-8581-6459E3F991C2Q33914771-9EA29035-05D7-48A7-A4ED-0715F22D7BFEQ34045119-06EDEA5F-60FA-4C11-9F4D-E9D1AD421AB5Q34047136-F46FF949-985C-4969-8238-16E0DFB53E11Q34615075-858CA19F-0195-43CF-877B-2670CB1479CAQ35034547-E716F0C4-987D-4F17-8186-45C7358E8B47Q35100982-FD11FE03-CE6A-495F-BD5E-11FA68803193Q35214291-3AF42BD2-2992-4931-BD7C-94DFAD0ADD0CQ35357207-47AF0339-B844-4961-85BA-B08ACC729F61Q35499776-96EC4D82-9A83-457C-8D03-B9667C544DAAQ35574213-A401A8E6-9D95-4014-B376-BC2EBC6CB90AQ35619914-F0798F28-C1B2-484B-922E-86AF37AD57C6Q35782785-FF9D2B2E-681F-47DC-AE17-6F7D43B96A34Q36117093-8AD18695-4757-435E-9CB1-6C98F7A52340Q36179308-CA0FA0E0-26F7-4C9E-B294-9731F183F415Q36299217-1A6B720C-253A-4F89-889F-538F8BD3862FQ36396095-14F2A40C-4645-4037-A437-B2EEACC78D4DQ36427101-8D18DD74-5978-4075-B044-09141A231AA0Q36442636-C6F15F89-936E-455F-9CEE-C6F72F897AC1Q36509188-29DA8C80-6A79-4A7D-8E84-40B868E8F0FFQ36589179-011A0BD9-A589-45DE-B03A-BBC247579530
P2860
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
@ast
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
@en
type
label
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
@ast
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
@en
prefLabel
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
@ast
The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
@en
P2093
P2860
P1476
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
@en
P2093
Diego A Chiappetta
Eggehard Holler
Ezequiel Bernabeu
José A Rodríguez
Julia Y Ljubimova
Maggie Kozman
Manuel L Penichet
Shabnum Patel
Tracy R Daniels
P2860
P304
P356
10.1016/J.BBAGEN.2011.07.016
P407
P577
2011-08-05T00:00:00Z